Intelligent Bio Solutions Inc (INBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Sales | 1,061 | 970 | 1,112 | 710 | 729 |
| Cost of Goods | 525 | 437 | 594 | 508 | 388 |
| Gross Profit | 535 | 533 | 518 | 202 | 341 |
| Operating Expenses | 4,168 | 3,605 | 4,111 | 3,632 | 3,463 |
| Operating Income | -2,947 | -2,636 | -3,000 | -3,095 | -2,560 |
| Interest Expense | 4 | 56 | 4 | 17 | 8 |
| Other Income | 82 | 5 | 9 | 9 | 18 |
| Pre-tax Income | -2,870 | -2,687 | -2,995 | -3,103 | -2,551 |
| Net Income Continuous | -2,870 | -2,687 | -2,995 | -3,103 | -2,551 |
| Minority Interests | -7 | -9 | -12 | -13 | -7 |
| Net Income | $-2,863 | $-2,678 | $-2,983 | $-3,090 | $-2,544 |
| EPS Basic Total Ops | -1.80 | -2.82 | -3.50 | -3.63 | -4.41 |
| EPS Basic Continuous Ops | -1.80 | -2.83 | -3.50 | -3.64 | -4.42 |
| EPS Diluted Total Ops | -1.80 | -2.82 | -3.50 | -3.63 | -4.41 |
| EPS Diluted Continuous Ops | -1.80 | -2.83 | -3.50 | -3.64 | -4.42 |
| EPS Diluted Before Non-Recurring Items | -1.80 | -2.82 | -3.50 | -3.70 | -4.40 |
| EBITDA(a) | $-2,817 | $-2,308 | $-2,742 | $-2,859 | $-2,437 |